COVID-19
An Introduction to COVID-19
On 11 March 2020, the World Health Organization declared COVID-19 a pandemic. The impact on the medical community has been huge, not only on the front-line, but also for patients navigating treatment for neurological conditions during this unprecedented situation.
The touchNEUROLOGY expert faculty have been sharing their experiences and advice during this challenging time through video interviews and short articles.
Our supporting partners do not constitute an endorsement of the content on this page.
Leading experts share their perspectives on the most important therapeutic and treatment updates at AAN 2026 and discuss how these findings may shape the future of neurologic care At American Academy of Neurology (AAN) Annual Meeting, Chicago, IL, USA, April 18–22, 2026, major ...
Emerging data from AAN 2026 across neuroimmunology, epilepsy, neuromuscular disease, movement disorders and neuroinfectious disease highlighted the continued evolution of neurology toward more precise, personalized and mechanism-driven care. The American Academy of Neurology (AAN) Annual Meeting, Chicago, IL, USA, from April 18–22, 2026, ...
In our inaugural touchNEUROLOGY Future Leaders 2025 campaign, we celebrate the next generation of neurologists, rising stars shaping the future of clinical practice, research, and education across neurological specialties.
As touchNEUROLOGY approaches 20 years of providing education for busy neurologists, we are looking to the future—and it certainly looks bright!
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
In this episode, we’re joined by Bradley Love, Professor of Cognitive and Decision Sciences at UCL, ELLIS fellow, and creator of BrainGPT. We discuss how this large language model is poised to assist researchers in advancing their work.
The coronavirus disease 2019 (COVID-19) pandemic has led to unprecedented illness and death among the global population. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can range from mild upper respiratory symptoms that subside with no lasting effects to multiorgan system failure ...
Two cases of COVID-19 vaccination associated neurological symptoms were presented, with patients displaying parkinsonism and cognitive dysfunction. In this touchNEUROLOGY interview, we speak with Dr Suman Kushwaha (Institute of Human Behaviour and Allied Sciences (IHBAS), Dilshad Garden, Delhi, India) to ...
Neurological complications, such as peripheral neuropathy, have been associated with COVID-19 vaccination. In this touchNEUROLOGY interview, we speak with Dr Suman Kushwaha (Institute of Human Behavior and Allied Sciences (IHBAS), Dilshad Garden, Delhi, India) to discuss the neurological symptoms that ...
Headache is one of the most common nervous system disorders. In an interview with touchNEUROLOGY, Dr Raquel Gil-Gouveia (Hospital da Luz, Lisbon, Portugal) summarizes the ePoster session she chaired at EAN 2022, ranging from topics such as how COVID-19 has impacted ...
Functional neurological symptoms have been observed in young people globally during the COVID-19 pandemic, presenting with rapid onset of complex motor and vocal tic-like behaviours. Dr Davide Martino (Hotchkiss Brain Institute, University of Calgary, Calgary, Canada) discusses the rise in ...
touchNEUROLOGY joins Gabriel de Erausquin (UT Health San Antonio, TX, USA) at AAIC 2021 to discuss the Alzheimer's Association-led Global SARS-CoV-2 Consortium and the links between long-term cognitive dysfunction, acceleration of Alzheimer’s symptoms and COVID-19. Questions Could you tell us ...
touchNEUROLOGY joins Prof Munro Cullum (UT Southwestern Medical Center, Dallas, TX, USA) at AAIC 2021 to discuss the challenges faced during the COVID-19 pandemic and the impact of telehealth on clinical practice. Questions 1. What challenges to dementia research have been posed ...
A panel of internationally renowned experts provide an update on MS treatment and assessment practices in the context of COVID-19. For subtitles in French, German, Italian, Russian and Spanish, please click [CC] on the video player below.
Healthcare workers are currently facing the coronavirus disease 2019 (COVID-19) pandemic and its complications, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients usually suffer from respiratory problems and non-specific neurological symptoms, such as headache, dizziness and ataxia, as well as ...
touchNEUROLOGY met with Robert Shapiro (Larner College of Medicine at the University of Vermont, Burlington, VT, USA) to discuss the impact of COVID-19 on individuals with migraine. The abstract ‘Migraine Is Associated With Higher Incidence of COVID-19, and Higher Frequency ...
touchNEUROLOGY met with Robert Shapiro (Larner College of Medicine at the University of Vermont, Burlington, VT, USA) to discuss the impact of COVID-19 on individuals with migraine. The abstract ‘Migraine Is Associated With Higher Incidence of COVID-19, and Higher Frequency ...
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
